Table 1.
Descriptive statistics (Mean ± SD, [Min, Max], or N(%)) of patient characteristics.
| Total | Edmonton | MIND | STJ | Site difference, p-value* | |
|---|---|---|---|---|---|
| (N = 26) | (N = 13) | (N = 10) | (N = 3) | ||
| Sex, Male, N(%) | 22 (84.6%) | 10 (76.9%) | 9 (90.0%) | 3 (100.0%) | 0.765 |
| Leiter-III | |||||
| Baseline age, years | 13.15 ± 5.50 [6.18, 25.85] | 12.23 ± 5.68 [6.74, 25.85] | 15.46 ± 5.18 [6.18, 23.95] | 9.42 ± 3.18 [7.52, 13.09] | 0.176 |
| Duration of follow-up, years | 1.88 ± 0.63 [1.22, 2.99] | 1.71 ± 0.57 [1.28, 2.87] | 2.25 ± 0.64 [1.22, 2.99] | 1.45 ± 0.23 [1.27, 1.70] | 0.050 |
| Vineland ** | |||||
| Baseline age, years | 13.09 ± 5.61 [6.18, 25.85] | 12.24 ± 5.69 [6.74, 25.85] | 15.54 ± 5.50 [6.18, 23.96] | 9.42 ± 3.18 [7.52, 13.09] | 0.197 |
| Duration of follow-up, years | 2.09 ± 1.00 [1.05, 4.80] | 1.70 ± 0.55 [1.29, 2.87] | 2.88 ± 1.19 [1.05, 4.80] | 1.45 ± 0.23 [1.27, 1.70] | 0.006 |
*p-value was obtained by Fisher’s exact test or ANOVA for group comparison among the three sites. **A male subject from MIND was excluded from analysis due to missing baseline.